Form 8-K - Current report:
SEC Accession No. 0001104659-25-081995
Filing Date
2025-08-25
Accepted
2025-08-22 20:58:37
Documents
18
Period of Report
2025-08-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2524079d1_8k.htm   iXBRL 8-K 43170
2 EXHIBIT 4.1 tm2524079d1_ex4-1.htm EX-4.1 99357
3 EXHIBIT 4.2 tm2524079d1_ex4-2.htm EX-4.2 104723
4 EXHIBIT 10.1 tm2524079d1_ex10-1.htm EX-10.1 215398
5 EXHIBIT 10.2 tm2524079d1_ex10-2.htm EX-10.2 94917
6 EXHIBIT 99.1 tm2524079d1_ex99-1.htm EX-99.1 14837
10 GRAPHIC tm2524079d1_ex99-1img01.jpg GRAPHIC 4420
  Complete submission text file 0001104659-25-081995.txt   894003

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA imrx-20250821.xsd EX-101.SCH 3023
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE imrx-20250821_lab.xml EX-101.LAB 34239
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imrx-20250821_pre.xml EX-101.PRE 22364
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2524079d1_8k_htm.xml XML 3848
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40675 | Film No.: 251247704
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)